Please use this identifier to cite or link to this item: https://hdl.handle.net/10923/22799
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEduardo Luiz Pedrazza-
dc.contributor.authorEduardo Pacheco Rico-
dc.contributor.authorMario Roberto Senger-
dc.contributor.authorLeonardo Pedrazza-
dc.contributor.authorFernanda Francine Zimmermann-
dc.contributor.authorJoão José Freitas Sarkis-
dc.contributor.authorMaurício Reis Bogo-
dc.contributor.authorCarla Denise Bonan-
dc.date.accessioned2022-09-06T12:05:27Z-
dc.date.available2022-09-06T12:05:27Z-
dc.date.issued2008-
dc.identifier.issn0014-2999-
dc.identifier.urihttps://hdl.handle.net/10923/22799-
dc.language.isoen-
dc.relation.ispartofEuropean Journal of Pharmacology-
dc.rightsopenAccess-
dc.subjectNTPDase-
dc.subjectnucleotidases-
dc.subjectfluoxetine-
dc.subjectnortriptyline-
dc.titleEcto-nucleotidase pathway is altered by different treatments with fluoxetine and nortriptyline.-
dc.typeArticle-
dc.date.updated2022-09-06T12:05:26Z-
dc.identifier.doiDOI:10.1016/j.ejphar.2008.01.013-
dc.jtitleEuropean Journal of Pharmacology-
dc.volume583-
dc.issue1-
dc.spage18-
dc.epage25-
Appears in Collections:Artigo de Periódico



All Items in PUCRS Repository are protected by copyright, with all rights reserved, and are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Read more.